LOS ANGELES, January 16, 2018 /PRNewswire/ --
Cannabis Strategic Ventures, Inc. (OTC Pink: NUGS) today announcesthe engagement of L&L CPAs, PA as its independent audit firm. The firm will conduct a full audit and will assist in bringing the Company up to fully reporting status with the U.S. Securities & Exchange Commission.
"Full transparency is
Cannabis Strategic is also planning an uplisting of the Company's stock trading venue. Once the audit is completed, the Company will have a better idea which stock exchange is most appropriate for the Company. Mr. Yu continued, "With the completion of the audit, we will soon qualify to move the trading of our common shares to a new venue, which will further improve liquidity and open the Company up to new sources of funds to reduce our overall cost of capital. It's a goal we are working hard to obtain and we are already taking meaningful steps toward achievement."
L&L CPAs, PA is registered with the PCAOB and is experienced in conducting audits of public companies in the cannabis industry. Completing this audit will help ensure the accuracy and completeness of the Company's financial information.
Abut Cannabis Strategic Ventures
Cannabis Strategic Ventures is based in Los Angeles and is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. We help business owners launch their dreams. The Company, recently completed a name and symbol change from Cascade Energy, Inc. Cannabis Strategic Ventures offers outsourced personnel solutions that are tailor made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries, and other cannabis marketplace participants. Cannabis Strategic Ventures is publically traded on the U.S. Over the Counter Market with the stock symbol NUGS.
FORWARD-LOOKING STATEMENTS: This release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements also may be included in other publicly available documents issued by the Company and in oral statements made by our officers and representatives from time to time. These forward- looking statements are intended to provide management's current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified by the use of words such as "anticipate," "intend," "plan," "goal," "seek," "believe," "project," "estimate," "expect," "strategy," "future," "likely," "may," "should," "would," "could," "will" and other words of similar meaning in connection with a discussion of future operating or financial performance.
Examples of forward looking statements include, among others, statements relating to future sales, earnings, cash flows, results of operations, uses of cash and other measures of financial performance.
Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and other factors that may cause the Company's actual results and financial condition to differ materially from those expressed or implied in the forward- looking statements. Such risks, uncertainties and other factors include, among others such as, but not limited to economic conditions, changes in the laws or regulations, demand for products and services of the company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward looking statements.
Any forward-looking information provided in this release should be considered with these factors in mind. We assume no obligation to update any forward-looking statements contained in this report.
Contact: Phone: +1-310-359-6860 Email: email@example.com
SOURCE Cannabis Strategic Ventures, Inc.
Subscribe to our Free Newsletters!
Take the quiz on Rabies and test your knowledge about this infection that can affect the brain ...
Pneumonitis usually refers to inflammation of lung tissue due to various non-infective causes such ...
Fremanezumab-vfrm is used as a preventive treatment for a migraine headache in adult patients. It ...View All